$1.62 Billion Forecast for Cardiac Tissue Engineering Market by 2029, Backed by Demand and Innovation

Global Cardiac Tissue Engineering Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Cardiac Tissue Engineering Market Expected to Grow Between 2025 And 2029?

The market size of cardiac tissue engineering has seen a significant increase in the past few years. The market, which was valued at $0.67 billion in 2024, is expected to reach $0.8 billion by 2025, registering a compound annual growth rate (CAGR) of 19.4%. The expansion during the historical period was largely due to factors such as a shortage of organ donors, an increasing occurrence of cardiovascular diseases, advancements in biomaterial technologies, and rising investments in regenerative medicine. Additionally, there’s a surge in demand for personalized medicine, improvements in bioreactor systems, and an increase in government-backed funding for biomedical research. An emphasis on minimally invasive treatments has also contributed to this growth.

The market size for cardiac tissue engineering is poised for substantial expansion in the upcoming years. With a predicted compound annual growth rate (CAGR) of 19.2%, it is forecasted to achieve a worth of $1.62 billion by 2029. This expected rise during the forecast period can be credited to factors such as growing demand for individualized cardiac treatments, increased attention towards bioengineered heart tissues, and expansion in applications of regenerative medicine. Other key contributors include the surge in collaborations between academia and biotech companies, increased investments in preclinical testing platforms, and an escalating prevalence of chronic heart conditions. Future market trends are expected to include AI integration in tissue engineering, progression in nanotechnology-based scaffolding, biodegradable hydrogel development, advancement in the precision of 3D bioprinting, use of bioreactors for tissue maturation, and enhancement of cardiac cells through gene editing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21129&type=smp

What Are the Core Growth Drivers Propelling the Cardiac Tissue Engineering Market Forward?

The anticipated growth of the cardiac tissue engineering market is linked to the escalating prevalence of cardiovascular diseases. The interdisciplinary realm of cardiac tissue engineering concentrates on the development of biological or bioartificial constructs that mend, regenerate, or replace impaired heart tissue. Lifestyle choices such as unhealthy diets, lack of physical activity, tobacco use, the rising trend of obesity and diabetes primarily contribute to the increasing prevalence of cardiovascular diseases. Cardiovascular diseases employ cardiac tissue engineering, which creates biomaterials, cell-centric therapies, and bioengineered tissues that can repair or regenerate injured heart muscle and bring back cardiac functions. As an example, in May 2023, the Centers for Disease Control and Prevention, a US governmental body, reported a small climb in the percentage of coronary heart diseases in women aged 18 and above to 3.7% in 2023 from 3.6% in the previous year. Hence, the escalating rate of cardiovascular diseases is triggering the expansion of the cardiac tissue engineering market.

What Segment Types Define the Cardiac Tissue Engineering Market Structure?

The cardiac tissue engineeringmarket covered in this report is segmented –

1) By Product: Heart Valves, Vascular Grafts

2) By Material: Stem Cells, Scaffolds

3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications

4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users

Subsegments:

1) By Heart Valves: Bioprosthetic Heart Valves; Mechanical Heart Valves; Tissue-Engineered Heart Valves

2) By Vascular Grafts: Synthetic Vascular Grafts; Biologic Vascular Grafts; Tissue-Engineered Vascular Grafts

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21129&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cardiac Tissue Engineering Market?

North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theCardiac Tissue Engineering Industry Evolution?

Leading firms in the cardiac tissue engineering market are concentrating on creating technological innovations like 3D-engineered muscle tissues to improve the precision and effectiveness of drug discovery for potent treatments of cardiovascular diseases. 3D-engineered muscle tissues are bioengineered constructs that mimic human muscle’s structural and functional features, usually employed for drug trials and disease modeling. For instance, in July 2022, Curi Bio Inc., a biotech firm based in the US, introduced the Mantarray platform for pertinent human 3D heart and skeletal engineered muscle tissue (EMT) contractility scrutiny. This platform employs sophisticated tissue culture methods to produce highly operational muscle tissues that imitate the mechanical attributes and actions of natural muscle, providing a more precise model for drug testing. This technology aims to amplify the evolution of therapeutic solutions by giving researchers the ability to investigate muscle contraction, response to stimuli, and disease modeling at a microscopic level.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

What Is the Definition of the Cardiac Tissue Engineering Market?

Cardiac tissue engineering refers to the use of advanced biomedical techniques to develop functional heart tissue that can repair or regenerate damaged heart muscles. It involves combining cells, biomaterials, and bioactive factors to create engineered tissues that can restore cardiac function or aid in heart disease treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21129

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model